Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome.
Carvajal CA, Tapia-Castillo A, Vecchiola A, Baudrand R, Fardella CE.
J Clin Endocrinol Metab. 2020 Apr 1;105(4):dgz315. doi: 10.1210/clinem/dgz315.
Apparent mineralocorticoid excess.
Funder JW.
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):151-153. doi: 10.1016/j.jsbmb.2016.03.010. Epub 2016 Mar 5.
Apparent mineralocorticoid excess syndrome: an overview.
Palermo M, Quinkler M, Stewart PM.
Arq Bras Endocrinol Metabol. 2004 Oct;48(5):687-96. doi: 10.1590/s0004-27302004000500015. Epub 2005 Mar 7.
Apparent mineralocorticoid excess.
Funder JW.
Endocrinol Metab Clin North Am. 1995 Sep;24(3):613-21.
A Case of Liquorice-Infused Marijuana Causing Syndrome of Apparent Mineralocorticoid Excess.
Latif A, Naqi M, McAnally JF.
Eur J Case Rep Intern Med. 2023 Aug 21;10(9):003991. doi: 10.12890/2023_003991. eCollection 2023.
Apparent Mineralocorticoid Excess: Research as an Art Form.
Funder JW.
Endocrine. 2020 Dec;70(3):439-440. doi: 10.1007/s12020-020-02488-x.
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics.
Lu YT, Zhang D, Zhang QY, Zhou ZM, Yang KQ, Zhou XL, Peng F.
J Transl Med. 2022 Nov 3;20(1):500. doi: 10.1186/s12967-022-03698-9.
Low-Renin Hypertension.
Athimulam S, Lazik N, Bancos I.
Endocrinol Metab Clin North Am. 2019 Dec;48(4):701-715. doi: 10.1016/j.ecl.2019.08.003. Epub 2019 Sep 25.
Apparent mineralocorticoid excess syndromes.
Shimojo M, Stewart PM.
J Endocrinol Invest. 1995 Jul-Aug;18(7):518-32. doi: 10.1007/BF03349763.
11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.
Chapman K, Holmes M, Seckl J.
Physiol Rev. 2013 Jul;93(3):1139-206. doi: 10.1152/physrev.00020.2012.
